Interspinous Spacers Market revenue to surpass USD 138 Million by 2033, says Research Nester New York, Sept. 25, 2023 (GLOBE NEWSWIRE) -- The global interspinous spacers market size is projected to expand at ~6% CAGR between 2023 and 2033. The market is expected to garner a revenue of USD...

Sucampo Reports Results from Phase 2a Study of Intravenous Ion Channel Activator for Lumbar Spinal Stenosis BETHESDA, Md., Dec. 23, 2013 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Nasdaq:SCMP) (Sucampo) today announced the results of its double-blind, placebo-controlled Phase 2a proof of concept...

Sucampo Announces Positive Top-Line Results in Phase 1a Trials of Cobiprostone and SPI-3608 BETHESDA, Md., Aug. 7, 2013 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Nasdaq:SCMP) (Sucampo) today announced the positive top-line results of two recently completed clinical trials, a Phase...